Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 507 | nsp2:A507T; | CL-3d;CL-3e; |
| 507 | nsp2:A507V; | CL-1b;CL-3d;CL-3e; |
| 510 | nsp2:A510S; | CL-3e; |
| 518 | nsp2:A518T; | CL-3b; |
| 522 | nsp2:A522S; | CL-3b; |
| 522 | nsp2:A522T; | CL-3c;CL-3f; |
| 555 | nsp2:A555-; | CL-3b;CL-3e; |
| 555 | nsp2:A555S; | CL-3f; |
| 555 | nsp2:A555T; | CL-3b;CL-3d;CL-3e; |
| 555 | nsp2:A555V; | CL-1a_3b;CL-2;CL-3d;CL-3e;CL-5; |
| 59 | nsp2:A59-; | CL-3e; |
| 593 | nsp2:A593T; | CL-3d; |
| 593 | nsp2:A593V; | CL-3e; |
| 596 | nsp2:A596-; | CL-3f; |
| 596 | nsp2:A596D; | CL-3c; |
| 596 | nsp2:A596T; | CL-3e; |
| 59 | nsp2:A59V; | CL-3b;CL-3e; |
| 623 | nsp2:A623S; | CL-3c;CL-3e; |
| 80 | nsp2:A80-; | CL-1a;CL-1b; |
| 80 | nsp2:A80T; | CL-3c; |
| 80 | nsp2:A80V; | CL-3b;CL-3c;CL-3e; |
| 11 | nsp2:C11Y; | CL-3b; |
| 136 | nsp2:C136F; | CL-3b; |
| 136 | nsp2:C136G; | CL-3d;CL-3f; |
| 136 | nsp2:C136S; | CL-2;CL-3b;CL-3c; |
| 143 | nsp2:C143-; | CL-3e; |
| 146 | nsp2:C146-; | CL-3e;CL-4; |
| 164 | nsp2:C164-; | CL-3d; |
| 229 | nsp2:C229S; | CL-3e; |
| 240 | nsp2:C240Y; | CL-3b;CL-3e; |
| 253 | nsp2:C253F; | CL-3b;CL-3e;CL-3f; |
| 253 | nsp2:C253S; | CL-3d; |
| 253 | nsp2:C253Y; | CL-3c;CL-3e; |
| 326 | nsp2:C326F; | CL-3e; |
| 326 | nsp2:C326Y; | CL-1a_3e;CL-3d;CL-3f; |
| 33 | nsp2:C33F; | CL-3d; |
| 33 | nsp2:C33R; | CL-3b; |
| 33 | nsp2:C33Y; | CL-3e; |
| 475 | nsp2:C475-; | CL-3d; |
| 475 | nsp2:C475R; | CL-3e; |
| 475 | nsp2:C475Y; | CL-3b;CL-3e; |
| 477 | nsp2:C477F; | CL-3c; |
| 487 | nsp2:C487R; | CL-3c;CL-3e; |
| 487 | nsp2:C487W; | CL-3f; |
| 509 | nsp2:C509F; | CL-2; |
| 509 | nsp2:C509G; | CL-3d; |
| 509 | nsp2:C509S; | CL-3d; |
| 509 | nsp2:C509Y; | CL-3c;CL-3d; |
| 50 | nsp2:C50F; | CL-3b; |
| 50 | nsp2:C50R; | CL-5; |
Page 229 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com